Business
Press Release Sep 07 2022
Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 07-Sep-2022 titled "Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity.
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 07-Sep-2022 titled \"Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity. View Attachment","length":416,"tagName":"div"}]